Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07300904) titled 'Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial' on Dec. 21, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Stimuli Technology
Condition:
Overactive Bladder (OAB)
Intervention:
Device: Tensi+
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 60
Countries of Recruitment:
United States
Canada
United States
To know more, visit https://clinicaltrials.gov/study/NCT0...